Acute kidney injury in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: a population-based study from the United Kingdom

Antonio González-Pérez, Yanina Balabanova, María E Sáez, Gunnar Brobert, Luis A Garcia Rodriguez
doi: https://doi.org/10.1101/2022.04.17.22273705

Article Information

doi 
https://doi.org/10.1101/2022.04.17.22273705
History 
  • April 18, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Antonio González-Pérez1,*,
  2. Yanina Balabanova2,
  3. María E Sáez1,
  4. Gunnar Brobert3 and
  5. Luis A Garcia Rodriguez1
  1. 1Pharmacoepidemiology, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain
  2. 2Integrated Evidence Generation, Bayer AG, Berlin, Germany
  3. 3Integrated Evidence Generation, Bayer AB, Stockholm, Sweden
  1. ↵*Corresponding author
    Email: agonzalez{at}ceife.es (AG-P)
Back to top
Posted April 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Acute kidney injury in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: a population-based study from the United Kingdom
Antonio González-Pérez, Yanina Balabanova, María E Sáez, Gunnar Brobert, Luis A Garcia Rodriguez
medRxiv 2022.04.17.22273705; doi: https://doi.org/10.1101/2022.04.17.22273705
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area